Facts About BMS-199264 hydrochloride Revealed
These trials showed clinically considerable pharmacokinetic interactions [seven] characterised by a lower during the clearance from the anticancer drug and for this reason elevated exposure. The interpretation of subsequent phase II and III clinical trials was difficult because it was not possible to administer a similar dose of chemotherapy within